Trial intelligence / Profile preview

Bioavailability of Dexketoprofen-Vit B vs Dexketoprofen in Healthy Subjects

NCT05027126Phase 1Completed

Sponsor
Laboratorios Silanes
Start
Feb 2019
Primary completion
Nov 2019
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 1, randomised, open-label trial of dexketoprofen, cyanocobalamin, thiamine and pyridoxine in pain (2 arms), sponsored by Laboratorios Silanes. Primary endpoints: Maximum observed concentration, Area under the curve from time zero to the last measurable concentration and 4 more. Started Feb 2019; status: completed.

02

Drugs

dexketoprofencyanocobalaminthiaminepyridoxine
03

Conditions

pain

Beyond the preview

Go deeper on NCT05027126.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05027126.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call